MRE-269 857 Smiles: CN1C=C(C=N1)NC1=NC2=CC=C(CC#N)N=C2C(N[C@@H]2CC[C@H](CC2)N2CCN(CC2)C(=O)OC)=N1

Smiles: CN1C=C(C=N1)NC1=NC2=CC=C(CC#N)N=C2C(N[C@@H]2CC[C@H](CC2)N2CCN(CC2)C(=O)OC)=N1

CAS Number: 1782-55-4

which has been traditionally used in oriental medicine to treat headaches

Kazinol B has the potential for diabetes mellitus research

3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid

MRE-269 857 Smiles: CN1C=C(C=N1)NC1=NC2=CC=C(CC#N)N=C2C(N[C@@H]2CC[C@H](CC2)N2CCN(CC2)C(=O)OC)=N1MRE 269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. Product information CAS Number: 475085 57 5 Molecular Weight: 419. 52 Formula: C25H29N3O3 Chemical Name: 2 {4 [(5,6 diphenylpyrazin 2 yl)(propan 2 yl)amino]butoxy}acetic acid Smiles: CC(C)N(CCCCOCC(O)=O)C1C=NC(=C(N=1)C1C=CC=CC=1)C1C=CC=CC=1 InChiKey: OJQMKCBWYCWFPU UHFFFAOYSA N InChi: InChI=1S C25H29N3O3 c1 19(2)28(15 9 10 16 31 18 23(29)30)22 17 26 24(20 11 5 3